- The trend backdrop is active with a 3-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
TATVA
NSI
Week ended 31 Jul 2026
Weekly Investor Report
Tatva Chintan Pharma Chem Limited · Basic Materials · Specialty Chemicals
Latest close
1,788 INR
3.8%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 42.4% above the Trend Line and sits at 94.6% of its 52-week range. The latest completed week returned 3.8%, after a 43.1% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is expensive relative to peers. The latest news-sentiment score is 55/100. Near-term considerations: price is close to its 52-week high.
Setup score
68
out of 100
Latest Close
1,788 INR
31 Jul 2026
1W Return
3.8%
latest completed week
4W Return
43.1%
short-term follow-through
12W Return
32.3%
quarterly tape
Trend Breadth
55.8%
29 of 52 weeks active
Volume Ratio
1.1x
vs 13-week average
- Activity pressure is weak, so confirmation is not yet broad enough.
- 1 reversal markers appear in the recent smart-money tape.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
3.8%
Latest completed week; four-week move 43.1%.
Indicator stack
41/100
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
55/100
25 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 42.4% above the Trend Line and sits at 94.6% of its 52-week range. The latest completed week returned 3.8%, after a 43.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.1x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.4312-week average 0.34
12-week confirmation
Trend active3/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.43Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers11 reversal markers
No recent accumulation markers. 1 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 43.1% over four weeks, 32.3% over 12 weeks, and 60.5% over one year. The current trend has remained active for 3 consecutive weeks.
Performance by holding period
Active trend streak3 weeks
Active weeks in one year29
Trend breadth55.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.28Latest activity-pressure read.
Pressure change1796.7%Four-week change in activity pressure.
Leadership45.05Latest relative-leadership reading.
RS change728.3%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is expensive relative to peers.
Factor week 26 Jul 2026
Financial statements through 31 Mar 2026
Field coverage 94%
Model confidence 94%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength13/100Blend of value, momentum, and quality. Underlying universe rank 88; rank 1 is best.
Value6/100Relative valuation strength. Underlying universe rank 95; rank 1 is best.
Quality23/100Profitability and accounting quality. Underlying universe rank 78; rank 1 is best.
Momentum87/100Medium-term price momentum. Underlying universe rank 14; rank 1 is best.
Growth97/100Revenue and earnings growth. Underlying universe rank 4; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework8/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 78.4x Price divided by trailing earnings.
- Price / sales
- 7.2x Market value relative to trailing revenue.
- EV / EBITDA
- 37.0x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -2.0% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 56.6% Gross profit retained from each unit of revenue.
- Operating margin
- 12.5% Operating profit retained from revenue.
- Free-cash-flow margin
- -14.8% Free cash flow generated from revenue.
- Return on invested capital
- 5.8% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 32.2% Latest one-year revenue growth.
- EPS growth
- 636.1% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 6/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 0.1% Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.1% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 1.0x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment55/100
Weighted news tone is neutral across 25 relevant articles.
7 positive · 17 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-2.6%Distance below the 52-week high.
13-week volatility7.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
6 Mar
3 Apr
1 May
29 May
26 Jun
31 Jul
Weeks higher15 of 2611 weeks finished lower.
Best week+20.6%Week of 24 Jul.
Worst week-9.8%Week of 22 May.
Latest week+3.8%Week of 31 Jul.
Shape of recent returns
Strong gains8
Modest gains7
Flat weeks0
Modest losses8
Sharp losses3
Recent vol7.0%13-week weekly-return volatility.
Base vol6.7%52-week weekly-return volatility.
Up/down split29/23Count of positive and negative weeks in the 52-week window.
Average skew5.5% / -4.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Basic Materials
4-week rank- / 100
Group average-0.3%
Trend breadth49.0%
Trend49.0%active weekly trend signals
MD53.0%positive activity pressure
RS57.0%positive relative leadership
Four-week leaders
IndustryIN Specialty Chemicals
4-week rank2 / 100
Group average2.6%
Trend breadth70.0%
Trend70.0%active weekly trend signals
MD80.0%positive activity pressure
RS68.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape63/100
Trend, activity pressure, participation, and risk combine to a 63/100 tape read.
Indicator analysis53/100Latest 12-week confirmation: trend 3/12, activity pressure 8/12, relative leadership 12/12.
Activity pressure 0.43; 1 reversal markers Factors29/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 64; Small Cap Core rank 95 SVQF8/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 1462.5 of 1590 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment55/100Weighted news tone is neutral across 25 relevant articles.
Tatva Chintan Consolidated June 2026 Net Sales at Rs 167.06 crore, up 42.95% Y-o-Y Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 31 Jul 2026 | 1,788 INR | 3.8% | 1,256 INR | 1,157 INR | 1.28 | 45.05 | 775.0K | On |
| 24 Jul 2026 | 1,722 INR | 20.6% | 1,243 INR | 1,156 INR | 1.03 | 44.87 | 5.7M | On |
| 17 Jul 2026 | 1,428 INR | 7.7% | 1,229 INR | 1,156 INR | 0.55 | 18.52 | 481.0K | On |
| 10 Jul 2026 | 1,326 INR | 6.2% | 1,228 INR | 1,157 INR | 0.16 | 11.48 | 280.4K | Off |
| 3 Jul 2026 | 1,250 INR | 5.8% | 1,232 INR | 1,159 INR | -0.08 | 5.44 | 228.0K | Off |
| 26 Jun 2026 | 1,181 INR | -1.1% | 1,236 INR | 1,163 INR | -0.24 | 0.99 | 0 | Off |
| 19 Jun 2026 | 1,194 INR | -1.2% | 1,246 INR | 1,167 INR | -0.20 | 2.81 | 16.8K | Off |
| 12 Jun 2026 | 1,208 INR | 2.1% | 1,254 INR | 1,171 INR | -0.04 | 6.33 | 65.0K | Off |
| 5 Jun 2026 | 1,184 INR | 4.4% | 1,263 INR | 1,175 INR | 0.15 | 5.83 | 23.7K | Off |
| 29 May 2026 | 1,133 INR | -4.6% | 1,274 INR | 1,178 INR | 0.47 | 1.10 | 244.0K | Off |
| 22 May 2026 | 1,188 INR | -9.8% | 1,284 INR | 1,181 INR | 0.62 | 5.67 | 384.2K | Off |
| 15 May 2026 | 1,316 INR | -2.6% | 1,289 INR | 1,184 INR | 0.50 | 18.13 | 233.9K | Off |
| 8 May 2026 | 1,352 INR | 3.1% | 1,289 INR | 1,186 INR | 0.35 | 19.88 | 311.8K | Off |
| 1 May 2026 | 1,311 INR | 3.2% | 1,280 INR | 1,188 INR | -0.04 | 18.34 | 195.8K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.